Overlooked and Underfollowed
Value, special situations, long only

Stereotaxis - Trading At A Discount To Robotic Peers. Look For This Discount To Close As Sales Growth Resumes

Here is an overview on what the numbers suggest is the one of the cheapest robotic medical device manufacturers today, Stereotaxis (NASDAQ: STXS). Look for revenue growth to resume for STXS in 2014 and beyond driven by entry into Japan as well as VDrive approval helping close significant discount to peers.

Stereotaxis Raised Capital At Significantly Higher Valuations When It Was A Private Company When Growth Expectations Were High But Overall Sales Were Low. Look For Expectations For Growth To Resume Off Significantly Higher Revenue Base Which Should Drive Valuation Higher Once Again As Balance Sheet No Longer At Risk.

Before Stereotaxis went public in 2004, it raised $127 million as a private company with several strategic investors including...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details